Acute kidney injury (AKI) is a common complication in cardiac surgery associated with increased postoperative morbidity and mortality.
1-4 Even moderate impairment of kidney function carries significant prognostic implications.
5,6 Many causes and risk factors of AKI have been described, but measures to prevent or treat kidney injury have had limited success.
1,2,7 Maintenance of an adequate hemodynamic state and kidney perfusion is essential during cardiopulmonary bypass (CPB) and after surgery.
1,2,8 However, sufficient evidence for a preventive effect of pharmacologic drugs on AKI has not been achieved.
1,2,7